文献速递眼底病与葡萄膜炎

视网膜细胞瘤患者临床特征分析

[Clinical features of patients with retinocytoma].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2021-01-01

回顾性分析2006至2019年收治的10例(12只眼)视网膜细胞瘤患者,中位确诊年龄14岁,最常见首发症状为斜视。瘤体平均最大基底径5.70 mm、平均厚度2.28 mm,眼底以半透明视网膜占位、钙化团及边界明显的视网膜色素上皮改变为特征。平均随访28.7个月,所有瘤体稳定无恶性转化,提示为良性肿瘤但需密切随访。

要点

  • 视网膜细胞瘤好发于儿童及青年,中位确诊年龄14岁,斜视为最常见首发症状。
  • 特征性眼底表现包括半透明视网膜占位、钙化团和边界清晰的视网膜色素上皮改变。
  • 退化类型以3型最多见,平均随访28.7个月未见恶性转化。

核心结论

  • 视网膜细胞瘤是临床较少见的良性视网膜肿瘤,具有半透明视网膜占位病变等特征性眼底表现,应予以定期随访。

研究设计与样本

  • 回顾性系列病例研究,纳入复旦大学附属眼耳鼻喉科医院眼科2006年1月至2019年12月收治的10例(12只眼)临床确诊视网膜细胞瘤患者。

主要发现

  • 10例患者中男性7例、女性3例,确诊年龄5至39岁,中位年龄14岁。
  • 单眼发病8例,双眼发病2例,最常见首发症状为斜视4例。
  • 瘤体平均最大基底径5.70 mm(范围2.69至8.69 mm),平均厚度2.28 mm(范围0.61至3.76 mm)。
  • 12只眼均为单灶瘤体,后极部5个、中周部5个、周边部2个。
  • 眼底表现:半透明视网膜占位病变10个瘤体,钙化团11个瘤体,边界明显的视网膜色素上皮改变12个瘤体,脉络膜萎缩改变6个瘤体。

关键数值与推荐

  • 退化类型:1型瘤体2个,2型瘤体1个,3型瘤体9个,无4型瘤体。
  • 1例患者对侧眼合并视网膜母细胞瘤,基因检测提示RB1基因突变。
  • 平均随访28.7个月,所有患者瘤体均稳定,无恶性转化表现。

临床怎么用

  • 对具有半透明视网膜占位、钙化及边界清晰视网膜色素上皮改变的患者应考虑视网膜细胞瘤。
  • 确诊后应定期随访观察瘤体稳定性及有无恶性转化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To analyze the clinical features and fundus performance of patients with retinocytoma. Methods: Retrospective case series study. Ten patients (12 eyes) diagnosed with retinocytoma were enrolled in Department of Ophthalmology of Eye & ENT Hospital of Fudan University from January 2006 to December 2019. Clinical data were reviewed, including gender, age, initial symptoms, tumor size and location, fundus manifestations and regression patterns. Results: There were 7 males and 3 females aged from 5 to 39 years, with a median age of 14 years. Eight patients had unilateral retinocytoma, while 2 patients had bilateral retinocytoma. The most common complaints were strabismus (4 patients) and blurred vision (3 patients). The average maximum base diameter of the tumor was 5.70 mm (2.69 to 8.69 mm), and the average thickness was 2.28 mm (0.61 to 3.76 mm). Tumors in 12 eyes were all of a single focus, 5 in the posterior pole, 5 in the midperiphery and 2 in the periphery. Ophthalmoscopic features of retinocytoma included a translucent retinal mass in 10 eyes, a calcification mass in 11 eyes, with well-defined retinal pigment epithelial alteration in 12 eyes and a zone of chorioretinal atrophy in 6 eyes. The regression patterns were type 1 in 2 eyes, type 2 in 1 eye and type 3 in 9 eyes. The gene test showed RB1 mutation in 1 patient. During the average follow-up of 28.7 months, all of the tumors were stable without malignant transformation. Conclusions: Retinocytoma is a rare benign retinal tumor with characteristic fundus manifestations. Patients with retinocytoma should be monitored closely. (Chin J Ophthalmol, 2021, 57: 526-530). 目的: 分析视网膜细胞瘤眼底表现等临床特征。 方法: 回顾性系列病例研究。收集复旦大学附属眼耳鼻喉科医院眼科2006年1月至2019年12月收治的10例(12只眼)临床确诊为视网膜细胞瘤患者,整理记录临床资料,包括性别、年龄、首发症状及分析瘤体大小、位置,眼底表现,退化类型等。 结果: 10例患者中男性7例,女性3例;确诊年龄5~39岁,中位数为14岁;单眼发病8例,累及双眼2例。最常见首发症状为斜视4例,其余为视力差、眼前黑影或遮挡、体检发现异常。瘤体平均最大基底径为5.70 mm(范围2.69~8.69 mm),平均厚度为2.28 mm(范围0.61~3.76 mm)。12只眼均为单灶瘤体,后极部瘤体5个,中周部瘤体5个,周边部瘤体2个。眼底表现:10个瘤体为半透明视网膜占位病变,11个瘤体内含有钙化团,12个瘤体周围均伴边界明显的视网膜色素上皮改变,6个瘤体伴脉络膜萎缩改变。退化类型:1型瘤体2个,2型瘤体1个,3型瘤体9个,无4型瘤体。1例患者对侧眼合并视网膜母细胞瘤,基因检测提示RB1基因突变。平均随访28.7个月,所有患者瘤体均稳定,无恶性转化表现。 结论: 视网膜细胞瘤是临床较少见的良性视网膜肿瘤,具有半透明视网膜占位病变等特征性眼底表现,应予以定期随访。(中华眼科杂志,2021,57:526-530).

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yi XQ, Qian J, Guo J, et al. [Clinical features of patients with retinocytoma]. Zhonghua Yan Ke Za Zhi. 2021. PMID: 34256473. doi:10.3760/cma.j.cn112142-20200831-00564

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。